[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL2248825T3 - Fragmenty przeciwciała wiążące antygen do zastosowania w leczeniu i diagnozowaniu chorób oczu - Google Patents

Fragmenty przeciwciała wiążące antygen do zastosowania w leczeniu i diagnozowaniu chorób oczu

Info

Publication number
PL2248825T3
PL2248825T3 PL09159303T PL09159303T PL2248825T3 PL 2248825 T3 PL2248825 T3 PL 2248825T3 PL 09159303 T PL09159303 T PL 09159303T PL 09159303 T PL09159303 T PL 09159303T PL 2248825 T3 PL2248825 T3 PL 2248825T3
Authority
PL
Poland
Prior art keywords
antibody
treating
antigen binding
binding fragments
ocular diseases
Prior art date
Application number
PL09159303T
Other languages
English (en)
Inventor
Claire Abadie
Jean-Marc Combette
Catherine Deloche
Robert Anthony Williamson
Original Assignee
Ribovax Biotechnologies Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribovax Biotechnologies Sa filed Critical Ribovax Biotechnologies Sa
Publication of PL2248825T3 publication Critical patent/PL2248825T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PL09159303T 2009-05-04 2009-05-04 Fragmenty przeciwciała wiążące antygen do zastosowania w leczeniu i diagnozowaniu chorób oczu PL2248825T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09159303A EP2248825B1 (en) 2009-05-04 2009-05-04 Antigen binding fragments of an antibody for use in treating and diagnosing ocular diseases

Publications (1)

Publication Number Publication Date
PL2248825T3 true PL2248825T3 (pl) 2013-04-30

Family

ID=40740137

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09159303T PL2248825T3 (pl) 2009-05-04 2009-05-04 Fragmenty przeciwciała wiążące antygen do zastosowania w leczeniu i diagnozowaniu chorób oczu

Country Status (10)

Country Link
US (1) US8747856B2 (pl)
EP (1) EP2248825B1 (pl)
JP (1) JP2012526075A (pl)
AU (1) AU2010244465B2 (pl)
DK (1) DK2248825T3 (pl)
EA (1) EA022923B1 (pl)
ES (1) ES2395746T3 (pl)
PL (1) PL2248825T3 (pl)
PT (1) PT2248825E (pl)
WO (1) WO2010128053A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11267871B2 (en) * 2014-06-26 2022-03-08 Heiselberg ImmunoTherapeutics GmbH Topical application for an anti-HSV antibody
ZA201608812B (en) 2014-06-26 2019-08-28 Janssen Vaccines & Prevention Bv Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
SG11201610459XA (en) 2014-06-26 2017-01-27 Janssen Vaccines & Prevention Bv Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
EP3050897A1 (en) * 2015-01-28 2016-08-03 Polichem S.A. Human monoclonal antibodies endowed with strong neutralizing activity against HSV-1 and HSV-2
JP6816332B1 (ja) * 2020-04-14 2021-01-20 奥田　研爾 アデノウイルス結膜炎に対する医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1492383A (en) * 1974-03-16 1977-11-16 Seperic Therapeutic composition
US5646041A (en) * 1987-02-12 1997-07-08 Harfeldt; Elisabeth Monoclonal antibody to herpes simplex virus and cell line producing same
AU1257895A (en) * 1993-11-17 1995-06-06 Schepens Eye Research Institute, Inc., The Antibody to ocular and vaginal surface epithelium
WO1995018634A1 (en) * 1994-01-04 1995-07-13 The Scripps Research Institute Human monoclonal antibodies to herpes simplex virus and methods therefor
WO2003091413A2 (en) * 2002-04-23 2003-11-06 The Scripps Research Institute Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
AR042145A1 (es) * 2002-11-27 2005-06-08 Dow Agrociences Llc Produccion de inmunoglobulinas en plantas con una fucocilacion reducida
US6984492B2 (en) * 2003-09-05 2006-01-10 Talecris Biotherapeutics, Inc. Methods and compositions for treating herpes infections
AU2004298492B2 (en) * 2003-12-10 2011-08-18 E. R. Squibb & Sons, L.L.C. IP-10 antibodies and their uses
US20100028406A1 (en) * 2005-08-05 2010-02-04 Universite De Geneve Topical drug delivery by iontophoresis
US20110033389A1 (en) * 2009-04-29 2011-02-10 Zhifeng Chen Modified antibodies for passive immunotherapy

Also Published As

Publication number Publication date
DK2248825T3 (da) 2013-01-02
US20120165512A1 (en) 2012-06-28
ES2395746T3 (es) 2013-02-14
US8747856B2 (en) 2014-06-10
EA022923B1 (ru) 2016-03-31
JP2012526075A (ja) 2012-10-25
PT2248825E (pt) 2013-01-07
AU2010244465B2 (en) 2015-12-17
AU2010244465A1 (en) 2011-12-22
EP2248825B1 (en) 2012-09-19
EA201171352A1 (ru) 2012-05-30
EP2248825A1 (en) 2010-11-10
WO2010128053A1 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
HRP20190092T1 (hr) Antitijela i cjepiva za uporabu u terapijskim i dijagonstičkim postupcima za poremećaje vezane uz alfa-sinuklein
IL217030A0 (en) Biomarkers and methods for determining efficacy of anti-egfr antibodies in cancer therapy
HK1223114A1 (zh) 抗因子 單克隆抗體及其使用方法
IL207360A0 (en) Methods of diagnosing and treating parp - mediated diseases
PT2426148E (pt) Anticorpo anti-rá-il-3 para se utilizar no tratamento de tumores do sangue
HK1163119A1 (en) Anti cxcr4 antibodies and their use for the treatment of cancer cxcr4
IL214845A (en) Transgenic human antibody 1– dkk or part of its antigen-binding and pharmacological preparations containing it for use in cancer treatment
HRP20181973T1 (hr) Poboljšana anti humana fraktalkinska protutijela i njihova uporaba
EP2525813A4 (en) ANTIBODIES TO ILT5 AND ILT5 BINDING ANTIBODY FRAGMENTS
EP2631649A4 (en) METHOD AND DEVICE FOR FAST DIAGNOSIS OF DISEASES IN FAKE SAMPLE
EP2216344A4 (en) DIAGNOSIS AND TREATMENT OF CANCER WITH AN ANTI-GPR49 ANTIBODY
EP2323680A4 (en) PROTEINS FOR USE IN THE DIAGNOSIS AND TREATMENT OF INFECTIONS AND DISEASES
EP2396034A4 (en) ANTIBODIES AND METHODS FOR TREATING DISEASES ASSOCIATED WITH A STROGEN RECEPTOR
PT2504363T (pt) Anticorpos anticlusterina e fragmentos de ligação ao antigénio e a sua utilização para reduzir o volume de um tumor
EP2355849A4 (en) METHOD FOR IMPROVING THE THERAPEUTIC EFFECTIVENESS AND THE THERAPEUTIC UTILIZATION OF ANTIBODY FRAGMENTS
PT2248825E (pt) Fragmentos de antigénio ligantes a um anticorpo para uso no tratamento e diagnóstico de doenças oculares
EP2377891A4 (en) DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-LGR7 ANTIBODY
SI2066349T1 (sl) Humanizirana anti-cd19 protitelesa in njihova uporaba v zdravljenju tumorjev, transplantacijah in avtoimunih boleznih
EP2449126A4 (en) NEW ANTIBODIES AND THEIR USE IN THERAPY AND DIAGNOSTIC PROCEDURES
EP2281004A4 (en) PROSTATE-SPECIFIC MEMBRANANT ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS
EP2420515A4 (en) DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-TMPRSS11E ANTIBODY
EP2445539A4 (en) VALIDATION OF TARGETS OF THERAPEUTIC ANTIBODIES AND IN VIVO SCREENING
EP2484693A4 (en) ANTI-AMYLOID-A3 ANTIBODIES OF HUMAN SERUM AND USE THEREOF